|
Septicemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
On interaction with RAGE, these ligands stimulate downstream signaling that generates inflammation and oxidative stress leading to asthma, chronic obstructive pulmonary disease, lung cancers, idiopathic pulmonary fibrosis, acute lung injury, pneumonia, bronchopulmonary dysplasia, cystic fibrosis, and sepsis.
|
30457049 |
2019 |
|
Septicemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
AGER-Mediated Lipid Peroxidation Drives Caspase-11 Inflammasome Activation in Sepsis.
|
31440260 |
2019 |
|
Septicemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Taken together, these findings indicate that papaverine could become a useful therapeutic against HMGB1/RAGE-mediated sepsis and other inflammatory diseases.
|
30826057 |
2019 |
|
Septicemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Targeting RAGE by siRNA might attenuate hyperinflammation, improve survival rate, and offer new therapeutic options for sepsis.
|
28470354 |
2018 |
|
Septicemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Conclusions RAGE inhibition appears to have a beneficial impact on the outcome of sepsis in animal models, although there are discrepancies between different types of infection.
|
28760085 |
2018 |
|
Septicemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
|
29127203 |
2018 |
|
Septicemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Receptor for advanced glycation end products (RAGE) is implicated in inflammatory responses in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS), but its role in pulmonary edema formation remains unclear, especially in infection-related ARDS mainly caused by pneumonia or sepsis.
|
29040215 |
2018 |
|
Septicemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Overall, this study might provide valuable clinical evidence between the RAGE gene polymorphisms and the risk or the development of sepsis.
|
27172264 |
2017 |
|
Septicemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
RAGE-Mediated Suppression of Interleukin-10 Results in Enhanced Mortality in a Murine Model of Acinetobacter baumannii Sepsis.
|
28052995 |
2017 |
|
Septicemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
The receptor for advanced glycation end products (RAGE) has been demonstrated to be involved in the pathogenesis of sepsis.
|
28358333 |
2017 |
|
Septicemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Highlights of this study include: human SAA is possibly only expressed in a subset of septic patients; SAA induces HMGB1 release via TLR4 and RAGE receptors; SAA supplementation worsens the outcome of lethal endotoxemia; whereas SAA-neutralizing antibodies confer protection against lethal endotoxemia and sepsis.
|
26052716 |
2015 |
|
Septicemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Rs1800625 in the receptor for advanced glycation end products gene predisposes to sepsis and multiple organ dysfunction syndrome in patients with major trauma.
|
25572180 |
2015 |
|
Septicemia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Although genetic variants of the RAGE gene have been shown to be well associated with susceptibility to some inflammatory diseases, little is known about their clinical relevance in the development of sepsis in critical ill patients.
|
22827914 |
2012 |